5.70 -0.01 (-0.18%)
After hours: 4:01PM EDT
|Bid||5.72 x 1100|
|Ask||5.73 x 3200|
|Day's range||5.49 - 6.06|
|52-week range||4.08 - 11.10|
|Beta (5Y monthly)||1.77|
|PE ratio (TTM)||N/A|
|Earnings date||04 Aug 2021 - 09 Aug 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||7.13|
As an investor, mistakes are inevitable. But really big losses can really drag down an overall portfolio. So take a...
Clovis (CLVS) reports lower-than-expected loss for first-quarter 2021. Lower new patient start amid COVID-19 hurts U.S. sales of Rubraca. Stock up.
Clovis (CLVS) delivered earnings and revenue surprises of 11.11% and -15.14%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?